La Habra Startup Oculogenex to Research Vision Loss on International Space Station

(PRESS RELEASE) A biotech startup based in La Habra, CA, will launch research to the International Space Station aimed at preventing, and possibly reversing, age-related vision loss. The launch of SpaceX’s 30th Commercial Resupply Services mission is scheduled for no earlier than Thursday, March 21, 2024, at 4:55 EDT (1:55 PDT).

Read more about this exciting investigation aimed at preventing vision loss from age-related macular degeneration (AMD) in our ISS National Laboratory article:

ISS National Lab-Sponsored Study Tests a Novel Gene Therapy for Vision Loss

Dr. Hema Ramkumar, founder and CEO of biopharmaceutical company Oculogenex, also discussed the investigation during a pre-launch webinar, available on our launch page.

Feel free to contact us to learn more about how the ISS National Lab can help facilitate the space station for research that benefits humanity and creates a robust economy in low Earth orbit.